Clinical Trials · NCT07697391
AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- The First Affiliated Hospital of Anhui Medical University
- Enrollment
- 285
- Start date
- Jul 2026
- Locations
- 2 sites, China
- Primary endpoint
- Percent Change in Body Weight From Baseline to Week 52